ED
ONC

Exane Derivatives’s BeOne Medicines Ltd ONC Stock Holding History

Exane Derivatives’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-311
Closed -$113K – 1092
2021
Q3 		$113K Buy
311
+72
+30% +$23.5K 0.03% 506
2021
Q2 		$79K Sell
239
-126
-35% -$41.7K 0.02% 573
2021
Q1 		$127K Sell
365
-475
-57% -$157K 0.04% 380
2020
Q4 		$217K Buy
840
+80
+11% +$22K 0.06% 302
2020
Q3 		$218K Buy
760
+10
+1% +$2.35K 0.06% 207
2020
Q2 		$141K Hold
750
– – 0.04% 242
2020
Q1 		$92.3K Buy
+750
New +$117K 0.03% 289

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return